Dr. D’Angelo on Selecting CAR T-Cell Therapy or Transplantation in DLBCL
Christopher R. D’Angelo, MD, discusses factors that determine whether CAR T-cell therapy or autologous stem cell transplant should be used in patients with relapsed/refractory diffuse large B-cell lymphoma.
Dr. D’Angelo on Future Directions With CAR T-Cell Therapy in Lymphoma
Christopher R. D’Angelo, MD, discusses advances made with CAR T-cell therapy in lymphoma.